| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | Feb 20, 2023 | Sale | $0.65 | 537 | 349 | 3,049 | Nov 28, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 27, 2023 | Sale | $0.19 | 478,396 | 91,661 | 571,796 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | Sep 27, 2023 | Sale | $0.19 | 1,489,512 | 285,390 | 1,780,317 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 28, 2023 | Sale | $0.16 | 2,858,980 | 450,289 | 0 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 27, 2023 | Sale | $0.19 | 2,391,981 | 458,304 | 2,858,980 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 28, 2023 | Sale | $0.16 | 1,937,852 | 305,212 | 0 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | Sep 28, 2023 | Sale | $0.16 | 571,796 | 90,058 | 0 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | Sep 27, 2023 | Sale | $0.19 | 1,621,313 | 310,644 | 1,937,852 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 28, 2023 | Sale | $0.16 | 1,780,317 | 280,400 | 0 | Sep 29, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 26, 2023 | Sale | $0.20 | 1,461,849 | 293,393 | 3,559,165 | Sep 28, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 26, 2023 | Sale | $0.20 | 431,343 | 86,571 | 1,050,192 | Sep 28, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 26, 2023 | Sale | $0.20 | 1,343,011 | 269,542 | 3,269,829 | Sep 28, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 26, 2023 | Sale | $0.20 | 2,156,717 | 432,853 | 5,250,961 | Sep 28, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 25, 2023 | Sale | $0.25 | 67,767 | 16,942 | 5,021,014 | Sep 27, 2023, 05:53 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 25, 2023 | Sale | $0.25 | 19,996 | 4,999 | 1,481,535 | Sep 27, 2023, 05:53 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 25, 2023 | Sale | $0.25 | 62,258 | 15,565 | 4,612,840 | Sep 27, 2023, 05:53 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III - Parallel Fund (A) L.P. | 10% Owner | Sep 25, 2023 | Sale | $0.25 | 99,979 | 24,995 | 7,407,678 | Sep 27, 2023, 05:53 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 22, 2023 | Sale | $0.26 | 2,031,313 | 525,704 | 7,507,657 | Sep 26, 2023, 05:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III L.P. | 10% Owner | Sep 22, 2023 | Sale | $0.26 | 1,376,848 | 356,328 | 5,088,781 | Sep 26, 2023, 05:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 22, 2023 | Sale | $0.26 | 406,263 | 105,141 | 1,501,531 | Sep 26, 2023, 05:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 22, 2023 | Sale | $0.26 | 1,264,920 | 327,361 | 4,675,098 | Sep 26, 2023, 05:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 21, 2023 | Sale | $0.30 | 506,951 | 152,339 | 1,907,794 | Sep 25, 2023, 08:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III L.P. | 10% Owner | Sep 21, 2023 | Sale | $0.30 | 1,578,419 | 474,315 | 5,940,018 | Sep 25, 2023, 08:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 21, 2023 | Sale | $0.30 | 2,534,754 | 761,694 | 9,538,970 | Sep 25, 2023, 08:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 21, 2023 | Sale | $0.30 | 1,718,087 | 516,285 | 6,465,629 | Sep 25, 2023, 08:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 20, 2023 | Sale | $0.31 | 2,101,784 | 652,814 | 8,183,716 | Sep 22, 2023, 04:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III L.P. | 10% Owner | Sep 20, 2023 | Sale | $0.31 | 620,167 | 192,624 | 2,414,745 | Sep 22, 2023, 04:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III - Parallel Fund (A) L.P. | 10% Owner | Sep 20, 2023 | Sale | $0.31 | 1,930,923 | 599,745 | 7,518,437 | Sep 22, 2023, 04:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 20, 2023 | Sale | $0.31 | 3,100,836 | 963,120 | 12,073,724 | Sep 22, 2023, 04:15 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 19, 2023 | Sale | $0.37 | 2,819,506 | 1,031,939 | 10,285,500 | Sep 21, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CR Group L.P. | 10% Owner | Sep 19, 2023 | Sale | $0.37 | 831,943 | 304,491 | 3,034,912 | Sep 21, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Unlev AIV I L.P. | 10% Owner | Sep 19, 2023 | Sale | $0.37 | 2,590,300 | 948,050 | 9,449,360 | Sep 21, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CRG Partners III (Cayman) Lev AIV I L.P. | 10% Owner | Sep 19, 2023 | Sale | $0.37 | 4,159,717 | 1,522,456 | 15,174,560 | Sep 21, 2023, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Mar 28, 2023 | Sale | $0.48 | 239 | 115 | 6,612 | Apr 06, 2023, 01:08 PM | |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | Feb 22, 2023 | Sale | $0.65 | 537 | 349 | 841 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 22, 2023 | Sale | $0.65 | 1,545 | 1,004 | 5,502 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 28, 2023 | Sale | $0.59 | 1,148 | 677 | 7,268 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 22, 2023 | Sale | $0.65 | 2,145 | 1,394 | 5,188 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 28, 2023 | Sale | $0.59 | 1,585 | 935 | 6,517 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | Chairman and CEO | Feb 22, 2023 | Sale | $0.65 | 6,875 | 4,469 | 13,560 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | Chairman and CEO | Feb 28, 2023 | Sale | $0.59 | 2,898 | 1,710 | 17,329 | Mar 09, 2023, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | Nov 10, 2022 | Sale | $1.79 | 1,292 | 2,317 | 2,253 | Nov 22, 2022, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | Chairman, CEO, and President | Apr 07, 2022 | Buy | $0.50 | 30,000 | 15,000 | 221,773 | Apr 11, 2022, 10:07 AM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Apr 08, 2022 | Buy | $0.50 | 12,952 | 6,476 | 181,945 | Apr 11, 2022, 09:55 AM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Apr 07, 2022 | Buy | $0.49 | 10,000 | 4,900 | 166,651 | Apr 11, 2022, 09:50 AM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Apr 08, 2022 | Buy | $0.48 | 10,000 | 4,767 | 152,350 | Apr 11, 2022, 09:40 AM | |
| TTOO | T2 Biosystems, Inc. | Giffin Brett A. | Chief Commercial Officer | Apr 08, 2022 | Buy | $0.49 | 10,600 | 5,183 | 10,600 | Apr 11, 2022, 09:38 AM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Mar 14, 2022 | Option Exercise | $0.36 | 11,428 | 4,160 | 168,993 | Mar 30, 2022, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 24, 2022 | Option Exercise | $0.45 | 55,008 | 24,688 | 142,350 | Mar 29, 2022, 04:23 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 21, 2022 | Option Exercise | $0.47 | 3,775 | 1,759 | 51,639 | Mar 29, 2022, 04:17 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Mar 24, 2022 | Option Exercise | $0.44 | 8,790 | 3,876 | 156,651 | Mar 28, 2022, 06:42 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 24, 2022 | Option Exercise | $0.45 | 76,867 | 34,498 | 148,775 | Mar 28, 2022, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 21, 2022 | Option Exercise | $0.47 | 5,275 | 2,458 | 79,923 | Mar 28, 2022, 06:34 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 24, 2022 | Option Exercise | $0.45 | 55,008 | 24,688 | 136,196 | Feb 28, 2022, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Feb 24, 2021 | Option Exercise | $0.45 | 88,878 | 39,888 | 158,755 | Feb 28, 2022, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 24, 2022 | Option Exercise | $0.45 | 76,867 | 34,498 | 138,775 | Feb 28, 2022, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Sperzel John J III | See Remarks | Feb 24, 2022 | Option Exercise | $0.45 | 141,560 | 63,532 | 191,773 | Feb 28, 2022, 04:00 PM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Feb 21, 2021 | Option Exercise | $0.47 | 5,275 | 2,458 | 79,145 | Feb 23, 2022, 07:42 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 21, 2022 | Option Exercise | $0.47 | 3,775 | 1,759 | 45,485 | Feb 23, 2022, 07:40 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 21, 2022 | Option Exercise | $0.47 | 5,275 | 2,458 | 69,923 | Feb 23, 2022, 07:28 PM | |
| TTOO | T2 Biosystems, Inc. | Ahuja Aparna | Chief Medical Officer | Jan 06, 2022 | Sale | $0.48 | 61,988 | 29,754 | 107,611 | Jan 10, 2022, 04:19 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS & CO. LLC | 10% Owner | May 20, 2020 | Buy | $0.80 | 5,126 | 4,116 | 4,201,582 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS GROUP INC | 10% Owner | Mar 25, 2020 | Sale | $0.93 | 1,200 | 1,113 | 4,197,056 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS GROUP INC | 10% Owner | Apr 09, 2020 | Sale | $0.49 | 2,000 | 980 | 4,197,456 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS & CO. LLC | 10% Owner | May 06, 2020 | Sale | $0.55 | 52,400 | 28,909 | 4,209,556 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS GROUP INC | 10% Owner | May 12, 2020 | Sale | $0.55 | 5,000 | 2,730 | 4,198,956 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS GROUP INC | 10% Owner | May 19, 2020 | Sale | $0.83 | 20,656 | 17,204 | 4,199,287 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | GOLDMAN SACHS GROUP INC | 10% Owner | Mar 24, 2020 | Sale | $0.38 | 1,000 | 378 | 4,196,956 | Aug 03, 2021, 06:41 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | May 06, 2020 | Sale | $0.55 | 52,400 | 28,909 | 4,209,556 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | May 12, 2020 | Buy | $0.55 | 5,000 | 2,730 | 4,198,956 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | May 19, 2020 | Sale | $0.83 | 20,656 | 17,204 | 4,199,287 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | Mar 24, 2020 | Sale | $0.38 | 1,000 | 378 | 4,196,956 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | May 20, 2020 | Buy | $0.80 | 5,126 | 4,116 | 4,201,582 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | Mar 25, 2020 | Sale | $0.93 | 1,200 | 1,113 | 4,197,056 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Jones Adrian M | Director | Apr 09, 2020 | Sale | $0.49 | 2,000 | 980 | 4,197,456 | Aug 03, 2021, 06:39 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Mar 25, 2021 | Sale | $1.56 | 8,758 | 13,662 | 73,256 | Mar 25, 2021, 03:17 PM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Mar 17, 2021 | Sale | $1.86 | 12,494 | 23,239 | 74,420 | Mar 18, 2021, 04:34 PM | |
| TTOO | T2 Biosystems, Inc. | Pare Anthony | Chief Commercial Officer | Mar 17, 2021 | Sale | $1.84 | 9,620 | 17,701 | 31,612 | Mar 18, 2021, 04:34 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 23, 2021 | Sale | $2.06 | 7,280 | 14,997 | 65,347 | Feb 23, 2021, 02:23 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 23, 2021 | Sale | $2.04 | 5,250 | 10,710 | 35,485 | Feb 23, 2021, 02:19 PM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | Chief Operations Officer | Feb 23, 2021 | Sale | $2.06 | 7,280 | 14,997 | 65,247 | Feb 23, 2021, 02:14 PM | |
| TTOO | T2 Biosystems, Inc. | Sprague John M | Chief Financial Officer | Feb 24, 2020 | Sale | $0.82 | 4,166 | 3,416 | 22,222 | Mar 03, 2020, 12:39 PM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | SVP, Operations | Feb 24, 2020 | Sale | $0.82 | 5,808 | 4,763 | 46,294 | Feb 25, 2020, 06:24 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 24, 2020 | Sale | $0.82 | 5,808 | 4,763 | 60,779 | Feb 25, 2020, 06:22 PM | |
| TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | Feb 24, 2020 | Sale | $0.82 | 5,808 | 4,763 | 68,994 | Feb 25, 2020, 06:19 PM | |
| TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | Feb 11, 2020 | Sale | $0.77 | 3,200 | 2,464 | 64,802 | Feb 12, 2020, 05:35 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 11, 2020 | Sale | $0.77 | 3,200 | 2,464 | 56,587 | Feb 12, 2020, 05:31 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 03, 2020 | Sale | $0.88 | 3,283 | 2,889 | 53,954 | Feb 05, 2020, 05:02 PM | |
| TTOO | T2 Biosystems, Inc. | McDonough John | Director | Feb 03, 2020 | Sale | $0.88 | 23,754 | 20,904 | 489,114 | Feb 05, 2020, 05:01 PM | |
| TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | Feb 03, 2020 | Sale | $0.88 | 7,535 | 6,631 | 62,169 | Feb 05, 2020, 05:01 PM | |
| TTOO | T2 Biosystems, Inc. | McDonough John | Director | Jan 23, 2020 | Sale | $1.15 | 57,417 | 66,030 | 512,868 | Jan 27, 2020, 02:58 PM | |
| TTOO | T2 Biosystems, Inc. | Elsbree David B | Director | Jan 03, 2020 | Sale | $1.16 | 5,316 | 6,167 | 91,081 | Jan 07, 2020, 02:12 PM | |
| TTOO | T2 Biosystems, Inc. | Barclay Alec | SVP, Operations | Sep 11, 2019 | Sale | $2.92 | 4,210 | 12,293 | 42,102 | Sep 13, 2019, 06:05 AM | |
| TTOO | T2 Biosystems, Inc. | Cima Michael J. | Director | Jun 11, 2019 | Sale | $1.43 | 3,240 | 4,633 | 213,178 | Jun 13, 2019, 04:31 PM | |
| TTOO | T2 Biosystems, Inc. | Lapidus Stanley | Director | Jun 11, 2019 | Sale | $1.44 | 9,000 | 12,960 | 53,010 | Jun 13, 2019, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | CUMMING JOHN W | Director | Jun 11, 2019 | Sale | $1.43 | 3,420 | 4,891 | 23,580 | Jun 13, 2019, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | Elsbree David B | Director | Jun 11, 2019 | Sale | $1.44 | 3,600 | 5,184 | 83,108 | Jun 13, 2019, 04:30 PM | |
| TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Chief Scientific Officer | Feb 11, 2019 | Sale | $3.36 | 3,005 | 10,097 | 69,704 | Feb 12, 2019, 04:52 PM | |
| TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | General Counsel | Feb 11, 2019 | Sale | $3.36 | 3,005 | 10,097 | 57,237 | Feb 12, 2019, 04:51 PM | |
| TTOO | T2 Biosystems, Inc. | McDonough John | President & CEO | Feb 11, 2019 | Sale | $3.36 | 8,134 | 27,330 | 448,220 | Feb 12, 2019, 04:47 PM |
Menu